Reply

Affiliations

¹ The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
² Division of Gastroenterology, McGill University Health Centre, Montreal, Canada; 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
³ Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Comment

Robert P Hirten et al. Clin Gastroenterol Hepatol. 2021 Jun.

. 2021 Jun;19(6):1301-1302.

doi: 10.1016/j.cgh.2020.07.061. Epub 2020 Nov 26.

¹ The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
² Division of Gastroenterology, McGill University Health Centre, Montreal, Canada; 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
³ Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

No abstract available

Comment on

A User's Guide to De-escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease.
Hirten RP, Lakatos PL, Halfvarson J, Colombel JF. Hirten RP, et al. Clin Gastroenterol Hepatol. 2020 May;18(6):1336-1345. doi: 10.1016/j.cgh.2019.12.019. Epub 2019 Dec 27. Clin Gastroenterol Hepatol. 2020. PMID: 31887444 Review.
A User's Guide to De-Escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease.
Arebi N, Dyall L, Kamperidis N. Arebi N, et al. Clin Gastroenterol Hepatol. 2021 Jun;19(6):1300-1301. doi: 10.1016/j.cgh.2020.06.056. Epub 2020 Nov 26. Clin Gastroenterol Hepatol. 2021. PMID: 33248077 No abstract available.